Galera Therapeutics Inc (GRTX) plunge -16.20% in a week: will this be a lucky break through?

Witnessing the stock’s movement on the chart, on Wednesday, Galera Therapeutics Inc (NASDAQ: GRTX) set off with pace as it heaved 2.12% to $0.15, before settling in for the price of $0.15 at the close. Taking a more long-term approach, GRTX posted a 52-week range of $0.09-$3.59.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.00%. Meanwhile, its Annual Earning per share during the time was -2.39%. This publicly-traded company’s shares outstanding now amounts to $54.39 million, simultaneously with a float of $38.25 million. The organization now has a market capitalization sitting at $8.39 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1985, while the 200-day Moving Average is $0.6463.

Galera Therapeutics Inc (GRTX) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Galera Therapeutics Inc’s current insider ownership accounts for 29.69%, in contrast to 14.87% institutional ownership. According to the most recent insider trade that took place on Feb 08 ’24, this organization’s 10% Owner bought 150,000 shares at the rate of 0.17, making the entire transaction reach 25,650 in total value, affecting insider ownership by 8,043,203. Preceding that transaction, on Feb 07 ’24, Company’s 10% Owner bought 175,000 for 0.17, making the whole transaction’s value amount to 30,185. This particular insider is now the holder of 7,893,203 in total.

Galera Therapeutics Inc (GRTX) Earnings and Revenue Records

As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.28 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.4) by $0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Galera Therapeutics Inc (NASDAQ: GRTX) Trading Performance Indicators

Let’s observe the current performance indicators for Galera Therapeutics Inc (GRTX). It’s Quick Ratio in the last reported quarter now stands at 4.36. The Stock has managed to achieve an average true range (ATR) of 0.03.

In the same vein, GRTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.42.

Technical Analysis of Galera Therapeutics Inc (GRTX)

Going through the that latest performance of [Galera Therapeutics Inc, GRTX]. Its last 5-days volume of 6.29 million indicated improvement to the volume of 2.41 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 20.46% While, its Average True Range was 0.0303.

Raw Stochastic average of Galera Therapeutics Inc (GRTX) in the period of the previous 100 days is set at 25.55%, which indicates a major rise in contrast to 17.80% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 154.09% that was higher than 118.20% volatility it exhibited in the past 100-days period.